Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
Acute therapies continue to report strong growth compared to chronic ones.
Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)